Growth Metrics

Quest Diagnostics (DGX) Shares Repurchased (2016 - 2025)

Quest Diagnostics' Shares Repurchased history spans 17 years, with the latest figure at $300.0 million for Q4 2025.

  • On a quarterly basis, Shares Repurchased rose 98.68% to $300.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $726.0 million, a 70.42% increase, with the full-year FY2025 number at $450.0 million, up 198.01% from a year prior.
  • Shares Repurchased hit $300.0 million in Q4 2025 for Quest Diagnostics, up from $151.0 million in the prior quarter.
  • Over the last five years, Shares Repurchased for DGX hit a ceiling of $1.5 billion in Q2 2021 and a floor of $151.0 million in Q4 2024.
  • Historically, Shares Repurchased has averaged $433.3 million across 5 years, with a median of $336.5 million in 2022.
  • Biggest five-year swings in Shares Repurchased: surged 446.67% in 2021 and later tumbled 86.67% in 2022.
  • Tracing DGX's Shares Repurchased over 5 years: stood at $289.0 million in 2021, then skyrocketed by 59.52% to $461.0 million in 2022, then crashed by 40.35% to $275.0 million in 2023, then tumbled by 45.09% to $151.0 million in 2024, then surged by 98.68% to $300.0 million in 2025.
  • Business Quant data shows Shares Repurchased for DGX at $300.0 million in Q4 2025, $151.0 million in Q4 2024, and $275.0 million in Q4 2023.